Table 3 Grouped-level of diagnostic precision: multivariable logistic regression adjusted odds ratios with corresponding 95 % CIs (confidence intervals) for the most common disorders overall in French Bulldogs and non-French Bulldogs under primary veterinary care at UK practices participating in the VetCompass™ Programme from January 1st 2016 to December 31st, 2016. Model variables accounted for included age, sex-neuter status, at/above or below mean bodyweight, insurance status and veterinary group
Grouped-level disorder | French Bulldog Count (%) | Non-French Bulldog Count (%) | Adjusted odds ratio | 95 % CI** | P-value |
|---|---|---|---|---|---|
Upper respiratory tract disorder | 304 (10.9) | 757 (3.5) | 3.80 | 3.25 to 4.45 | < 0.001 |
Spinal cord disorder | 30 (1.1) | 225 (1.0) | 3.00 | 1.94 to 4.64 | < 0.001 |
Lower respiratory tract disorder | 27 (1.0) | 175 (0.8) | 2.99 | 1.85 to 4.83 | < 0.001 |
Congenital disorder | 38 (1.4) | 61 (0.3) | 2.73 | 1.78 to 4.18 | < 0.001 |
Brain disorder | 48 (1.7) | 374 (1.7) | 2.46 | 1.71 to 3.53 | < 0.001 |
Skin disorder | 548 (19.7) | 2724 (12.5) | 2.24 | 2.00 to 2.50 | < 0.001 |
Female reproductive disorder | 84 (3.0) | 317 (1.5) | 1.92 | 1.47 to 2.50 | < 0.001 |
Ear disorder | 340 (12.2) | 1769 (8.1) | 1.86 | 1.63 to 2.13 | < 0.001 |
Collapsed | 17 (0.6) | 267 (1.2) | 1.73 | 0.95 to 3.16 | 0.072 |
Ophthalmological disorder | 210 (7.6) | 1537 (7.0) | 1.47 | 1.25 to 1.73 | < 0.001 |
Urinary system disorder | 28 (1.0) | 267 (1.2) | 1.47 | 0.96 to 2.25 | 0.077 |
Heart disease | 44 (1.6) | 667 (3.1) | 1.43 | 1.02 to 2.01 | 0.041 |
Male reproductive disorder | 45 (1.6) | 198 (0.9) | 1.36 | 0.96 to 1.93 | 0.082 |
Anal sac disorder | 141 (5.1) | 1228 (5.6) | 1.31 | 1.08 to 1.58 | 0.006 |
Mass | 63 (2.3) | 1181 (5.4) | 1.29 | 0.98 to 1.71 | 0.072 |
Enteropathy | 391 (14.1) | 2276 (10.4) | 1.25 | 1.10 to 1.41 | 0.001 |
Musculoskeletal disorder | 168 (6.0) | 1927 (8.8) | 1.18 | 0.99 to 1.41 | 0.070 |
Thin | 42 (1.5) | 332 (1.5) | 1.13 | 0.79 to 1.61 | 0.509 |
Intoxication | 25 (0.9) | 139 (0.6) | 1.13 | 0.72 to 1.77 | 0.591 |
Neoplasia | 51 (1.8) | 1217 (5.6) | 1.04 | 0.77 to 1.41 | 0.809 |
Claw/nail disorder | 161 (5.8) | 1560 (7.1) | 0.94 | 0.79 to 1.12 | 0.478 |
Traumatic injury | 93 (3.3) | 811 (3.7) | 0.81 | 0.65 to 1.03 | 0.080 |
Adverse reaction to drug | 19 (0.7) | 160 (0.7) | 0.77 | 0.47 to 1.27 | 0.306 |
Parasite infestation | 105 (3.8) | 830 (3.8) | 0.76 | 0.61 to 0.94 | 0.012 |
Incontinence | 4 (0.1) | 206 (0.9) | 0.76 | 0.27 to 2.14 | 0.600 |
Foreign body | 31 (1.1) | 279 (1.3) | 0.71 | 0.48 to 1.04 | 0.080 |
Endocrine system disorder | 2 (0.1) | 195 (0.9) | 0.56 | 0.13 to 2.30 | 0.418 |
Behavioural issue | 65 (2.3) | 1164 (5.3) | 0.48 | 0.37 to 0.62 | < 0.001 |
Hernia | 24 (0.9) | 250 (1.1) | 0.37 | 0.24 to 0.56 | < 0.001 |
Dental disorder | 65 (2.3) | 3135 (14.3) | 0.30 | 0.23 to 0.38 | < 0.001 |
Lethargy | 7 (0.3) | 283 (1.3) | 0.24 | 0.11 to 0.51 | < 0.001 |
Complication associated with clinical care | 10 (0.4) | 413 (1.9) | 0.17 | 0.09 to 0.32 | < 0.001 |